Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect

Background: Accumulating data suggest that the state of the vaginal epithelium affects a woman's risk of HIV vaginal transmission and several human and non-human primate studies have shown that the rate of HIV or SIV vaginal transmission is decreased when estrogen is dominant. Systemic estrogen can protect against SIV vaginal transmission. Objective: To determine the safety and efficacy of topical estrogen in preventing SIV vaginal transmission. Design: The non-human primate model of HIV vaginal transmission was used to assess vaginal estriol cream in ovariectomized macaques. Methods: Twelve macaques were treated intravaginally with estriol and eight with placebo cream twice a week. The vaginal and systemic effects of estriol were determined by colposcopy and serum luteinizing hormone, levels of which would decline in the presence of systemic estrogen. After 5 weeks of therapy, the animals were challenged vaginally with pathogenic SIVmac251. Results: Vaginal estriol resulted in minimal serum estriol levels and had no effect on serum luteinizing hormone levels. Vaginal epithelia cornified and thickened significantly in response to estriol therapy. One of the estriol-treated animals became infected after this single challenge, while six of the control animals became infected (P = 0.0044). Conclusions: These data demonstrate that topical vaginal estriol can strongly protect against SIV vaginal transmission, while having no detectable systemic effect. These results support the study of topical vaginal estriol in preventing HIV vaginal transmission in at-risk women.

[1]  K. Mandaliya,et al.  The influence of vitamin A and hormonal contraception on HIV transmission and disease progression in women , 2003 .

[2]  P. Marx,et al.  Endometrial Hyperplasia, Polyps, and Adenomyosis Associated with Unopposed Estrogen in Rhesus Monkeys (Macaca mulatta) , 2002, Veterinary pathology.

[3]  R. Stouffer,et al.  Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle. , 2002, Molecular human reproduction.

[4]  P. Marx,et al.  Estrogen protects against vaginal transmission of simian immunodeficiency virus. , 2000, The Journal of infectious diseases.

[5]  B. Chohan,et al.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. , 1999, The Journal of infectious diseases.

[6]  H. Adami,et al.  Low-potency oestrogen and risk of endometrial cancer: a case-control study , 1999, The Lancet.

[7]  B. Richardson,et al.  Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. , 1998, The Journal of infectious diseases.

[8]  A. Gettie,et al.  Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. , 1998, AIDS research and human retroviruses.

[9]  P. Marx,et al.  A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route. , 1998, AIDS research and human retroviruses.

[10]  N. Sewankambo,et al.  HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis , 1997, The Lancet.

[11]  J. Ouslander,et al.  Postmenopausal vaginal atrophy and atrophic vaginitis. , 1997, The American journal of the medical sciences.

[12]  H. Whittle,et al.  Age of wife as a major determinant of male‐to‐female transmission of HIV‐2 infection: a community study from rural West Africa , 1996, AIDS.

[13]  D. Ho,et al.  Progesterone implants enhance SIV vaginal transmission and early virus load , 1996, Nature Medicine.

[14]  D. Spiegelman,et al.  Determinants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal study. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[15]  K. Hill.  The demography of menopause. , 1996, Maturitas.

[16]  B. Risberg,et al.  The vaginal epithelium in the postmenopause--cytology, histology and pH as methods of assessment. , 1995, Maturitas.

[17]  D. Gath,et al.  Sexual function in a community sample of middle-aged women with partners: Effects of age, marital, socioeconomic, psychiatric, gynecological, and menopausal factors , 1994, Archives of sexual behavior.

[18]  A. Gettie,et al.  Protection against vaginal SIV transmission with microencapsulated vaccine. , 1993, Science.

[19]  Kkk.  Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV. , 1992, BMJ.

[20]  Johnson.  Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV , 1992 .

[21]  D. Gerbaldo,et al.  Endometrial morphology after 12 months of vaginal oestriol therapy in post-menopausal women. , 1991, Maturitas.

[22]  J. Resko,et al.  Sex differences in biologically active and immunoreactive gonadotropins in the fetal circulation of rhesus monkeys. , 1980, Endocrinology.